[Current status in the commercialization and application of genetically modified plants and their effects on human and livestock health and phytoremediation].
Developments in the use of genetically modified plants for human and livestock health and phytoremediation were surveyed using information retrieved from Entrez PubMed, Chemical Abstracts Service, Google, congress abstracts and proceedings of related scientific societies, scientific journals, etc. Information obtained was classified into 8 categories according to the research objective and the usage of the transgenic plants as 1: nutraceuticals (functional foods), 2: oral vaccines, 3: edible curatives, 4: vaccine antigens, 5: therapeutic antibodies, 6: curatives, 7: diagnostic agents and reagents, and 8: phytoremediation. In total, 405 cases were collected from 2006 to 2010. The numbers of cases were 120 for nutraceuticals, 65 for oral vaccines, 25 for edible curatives, 36 for vaccine antigens, 36 for therapeutic antibodies, 76 for curatives, 15 for diagnostic agents and reagents, and 40 for phytoremediation (sum of each cases was 413 because some reports were related to several categories). Nutraceuticals, oral vaccines and curatives were predominant. The most frequently used edible crop was rice (51 cases), and tomato (28 cases), lettuce (22 cases), potato (18 cases), corn (15 cases) followed.
Research Center for Medicinal Plant Resources, National Institute of Biomedical Innovation, Ibaraki, Japan. yoshimat@nihio.go.jp
Kayo
K
Yoshimatsu
Noriaki
N
Kawano
Nobuo
N
Kawahara
Hiroshi
H
Akiyama
Reiko
R
Teshima
Masahiro
M
Nishijima
D000383:Agriculture / Q000706:statistics & numerical data*; D000818:Animals; D001673:Biodegradation, Environmental; D019649:Food Industry / Q000706:statistics & numerical data; D030841:Food, Genetically Modified; D006801:Humans; D058751:Livestock; D030821:Plants, Genetically Modified; D013997:Time Factors; D014481:United States / Q000453:epidemiology